Indicaciones del factor VII recombinante activado en hemorragia obstétrica grave

Corona-Gutiérrez, América Aime; García-Ruan, Karen; Camarena-Pulido, Eva Elizabet; López-Aceves, Luis Javier; González-Moreno, Jorge; Fajardo-Dueñas, Sergio.
Ginecol. obstet. Méx ; 86(12): 779-786, feb. 2018. tab, graf
Artigo em Espanhol | LILACS-Express | ID: biblio-1133987

Documentos relacionados

  1. Transcatheter arterial embolization for hemorrhage after gynecologic hysterectomy: a multicenter study.
  2. Factores asociados con mortalidad en la cirugía de control de daños en hemorragia obstétrica grave
  3. [Acute treatment with recombinant factor VII is probably indicated for intracerebral haematoma].
  4. Management and Morbidity of Major Pelvic Hemorrhage in Complex Abdominopelvic Surgery.
  5. Multidisciplinary Therapeutic Management in Complex Cervical Trauma.
  6. [Activated Factor VII - 31 years experience on clinical grounds].
  7. Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding.
  8. Patient blood management guideline for adults with critical bleeding.
  9. [The characteristics of digital subtraction angiography and the analysis of the therapeutic effect of interventional therapy on hemorrhage after partial nephrectomy].
  10. Patient adverse events and technical failures with the bravo capsule pH system: insights from the MAUDE database.